![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1367, 2002-01, pp. : 6-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Which cervical cancer screening interval and test is best?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 646, 2012-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Which screening strategy best for IBD?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 387, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Which antenatal screening strategy best bet in Scotland?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 485, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Breast cancer incidence and death increasing in less-developed countries
Cancer, Vol. 122, Iss. 3, 2016-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Which HPV screening options best in Thailand and Germany?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 627, 2011-01 ,pp. :